Skip to main content

Advertisement

Log in

The Greek (Hellenic) rheumatology over the years: from ancient to modern times

  • Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Rheumatology has its roots in ancient Greece. Hippocrates and other prominent Greek (Hellenes) physicians in ancient times, Hellenistic, Roman, and Byzantine period were acute observers of disease course and of patients and were able to define many disorders. They wrote books on various aspects of medicine and these writings were the basis of medical practice and education in Europe and the Arabic world well into the seventeenth century. In 1821, Greece emerged from a long occupation by the Turks. In 1930, Adamantiades, a Greek Ophthalmologist, before Behcet of Turkey, described what is known as (Adamantiades)–Behcet disease. The first scientific Hellenic Society for Rheumatology (ERE) was established in 1960 and today ERE having been merged with the Professional Union of Greek rheumatologists (EPERE) is known as ERE-EPERE. Rheumatology is a strong specialty with 348 rheumatologists for a population of around 11 million. Greek rheumatologists have contributed to rheumatology science and practice, and are active physicians participating in the American College of Rheumatology and the EULAR annual congresses and in many educational postgraduate courses. ERE-EPERE formed therapeutic protocols for inflammatory and autoimmune rheumatic diseases which were incorporated in the electronic National prescription system. Rheumatologists are authorized to use this platform to prescribe biologicals free of charge for patients. ERE-EPERE publishes a peer-reviewed English language journal, the Mediterranean Journal of Rheumatology (MJR), an open access journal with no publication fees. MJR is a quarterly journal with international Editorial Board.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Tirilomis T, Malliarou S (2003) Medical history and the European Union: papanicolaou and asklepios. Med J Aust 178(8):380

    PubMed  Google Scholar 

  2. Sanctuary of Asklepios at Epidaurus. UNESCO world Heritage Centre. http://whc.unesco.org. Culture:World Heritage Centre)

  3. Hippocrates with an English translation by WHS Jones. W.Heineman, London, Press HU, Cambridge MA. The Loeb classic library. Edited by Page TE, Capps E, Rouse WHD, Post IA, Warmington EH. http://ryanfb.github.io/loebolus-data/L17.pdf

  4. Nuki G, Simkin PA (2006) A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther 8(Suppl 1):S1–S5

    Article  PubMed  PubMed Central  Google Scholar 

  5. Sakkas LI, Daoussis D, Liossis SN, Bogdanos DP (2017) The infection besis of ACPA-positive rheumatoid arthritis. Front Microbiol 8:1853. https://doi.org/10.3389/fmicb.2017.01853

    Article  PubMed  PubMed Central  Google Scholar 

  6. Diamantopoulos A, Goudas P, Oreopoulos D (2009) Thirty-six Hippocratic aphorisms of nephrologic interest. Am J kidney Dis 54:143–153

    Article  Google Scholar 

  7. Feigenbaum A (1956) Description of Behcet’s syndrome in the Hippocratic third book of endemic diseases. Br J Ophthalmol 40:355–357

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Verity DH, Wallace GR, Vaughan RW, Stanford MR (2003) Behcet’s disease: from Hippocrates to the third millennium. Br J Ophthalmol 87:1175–1183

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Panourgias IG, Strangalis G, Stavrinou LC, Sakas DE (2011) The Hellenic and Hippocratic origins of the spinal terminology. J Hist Neurosci 20(3):177–187

    Article  Google Scholar 

  10. Askitopoulou H, Vgontzas AN (2018) The relevance of Hippocratic oath to the ethical and moral values of contemporary medicine. Part I: the Hippocratic oath from antiquity to modern times. Eur Spine J 27:1481–1490

    Article  PubMed  Google Scholar 

  11. Askitopoulou H, Vgontzas AN (2018) The relevance of Hippocratic oath to the ethical and moral values of contemporary medicine. Part II: Interpretation of the Hippocratic oath-today’s perspective. Eur Spine J 27:1491–1500

    Article  PubMed  Google Scholar 

  12. Clark SA (2018) The impact of Hippocratic oath in 2018: The conflict of the ideal of the physician, the knowledgeable humanitarian, versus the corporate medical Allegiance to financial models contributes to burnout. Cureus 10(7):e3076

    PubMed  PubMed Central  Google Scholar 

  13. Sallam HN (2010) Aristotle, the godfather of evidence-based medicine. FVV ObGyn 2:11–19

    CAS  Google Scholar 

  14. Wiltse LL (1998) Herophilus of Alexandria (325–255 B.C). The father of anatomy. Spine 23(17):1904–1914

    Article  CAS  PubMed  Google Scholar 

  15. Reveron RR (2014) Herophilus and Erasistratus, pioneers of anatomical dissection. Vesalius 20:55–58

    PubMed  Google Scholar 

  16. Santacroce L, Bottalico L, Charitos IA (2017) Greek medicine practice at ancient Rome: the physician molecularist Asclepiades. Medicines(Basel) 4:92–99. https://doi.org/10.3390/medicines4040092

    Article  Google Scholar 

  17. Pasipoularides A (2014) Galen, father of systematic medicine. An essay on the evolution of modern medicine and cardiology. Int J Cardiol 172:47

    Article  PubMed  Google Scholar 

  18. Herr HW (2017) From Galen’s urine to Harvey’s blood. Urology 106:6–8

    Article  PubMed  Google Scholar 

  19. Adams F (ed) (1956) The extant work of Aretaeus the Cappadocian. Syndenham Society, London. https://archive.org/details/b21510271

  20. Dunn PM (1995) Soranus of Ephesus (circa AD 98–138) and perinatal care in Roman times. Arch Dis Child 73:F51–F52

    Article  CAS  Google Scholar 

  21. Letts M (2016) Questioning the patient, questioning Hippocrates: Rufus of Ephesus and the limits of medical authority. Stud Anc Med 45:81–103

    PubMed  Google Scholar 

  22. Bujalkova M (2011) Rufus of Ephesus and his contribution to the development of anatomical nomenclature. Acta Med Hist Adriat 9:89–100

    PubMed  Google Scholar 

  23. Markatos K, Korres D, Chytas D et al (2018) Apolloius of Citium (first century BC) and his work on joint dislocations. Int Orthop 42(5):1191–1196

    Article  PubMed  Google Scholar 

  24. Bennett D (2000) Medical practice and manuscripts in Byzantium. Soc Hist Med 13:279–291

    Article  CAS  PubMed  Google Scholar 

  25. Scarborough J (1997) The life and times of Alexander of Tralles. Expedition 39:51–60

    Google Scholar 

  26. Knight V (2015) The “De podagra” (“On gout”): a pre-Gariopontean treatise excerpted from the latin translation of the Greek “Therapeutika” by Alexander of Tralles. Thesis. Manchester University

  27. Prioreschi P (2001) A history of medicine: Byzantine and Islamic medicine. Horatius Press, Omaha. http://books.google.gr/books?isbn=1888456043

  28. The Medical Works of Paul Aegineta, the Greek physician. Translated into English with copious commentary by Francis Adams, Esq. J Welsh, Treuttel, Wurtz & Co, London. The Library of the University of Toronto. http://ia.802703.us.archive.org/13/items/medicalworksofpa01pauluoft

  29. Gritzalis KC, Karamanou M, Androutsos G (2011) gout in the writings of eminent ancient Greek and Byzantine physicians. Acta Med-Hist Adriat 9:83–88

    PubMed  Google Scholar 

  30. Entezami P, Fox DA, Clapham PJ, Chung KC (2011) Historical perspective on the etiology of rheumatoid arthritis. Hand Clin 27:1–10. https://doi.org/10.1016/j.hcl.2010.09.006

    Article  PubMed  PubMed Central  Google Scholar 

  31. Short CL (1974) The antiquity of rheumatoid arthritis. Arthritis Rheum 17(3):193–205

    Article  CAS  PubMed  Google Scholar 

  32. Caughey DE (1974) The arthritis of constantine IX. Ann Rheum Dis 33:77–80

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Michael Psellos. Chronographia 1063. http://sourcebooks.fordham.edu/basis/psellus-chronographia.asp

  34. Zouboulis CC, Kaklamanis P (2003) Early descriptions of Adamantiades-Behcet’s disease. Ann Rheum Dis 62:691–692

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Adamantiades B (1931) Sur un cas d’ititis a hypopyon recidivant. Ann Ocul (Paris) 168:271–278

    Google Scholar 

  36. Vassilopoulos D, Delicha EM, Settas L et al (2016) Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective, real-life study. Clin Exp Rheumatol 34(5):693–900

    Google Scholar 

  37. Sfikakis PP, Bournia VK, Sidiropoulos P et al (2017) Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database. Clin Exp Rheumatol 35(4):579–585

    PubMed  Google Scholar 

  38. Panopoulos S, Tektonidou M, Drosos AA et al (2018) Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative multicenter, matched-cohort study. Arthritis Res Ther 20(1):267

    Article  PubMed  PubMed Central  Google Scholar 

  39. Vitali C, Bombardieri S, Jonsson R et al (2002) European study group on classification criteria for Sjögren’s syndrome. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 61(6):554–558

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Moutsopoulos HM (2007) Sjögren’s syndrome or autoimmune epithelitis? Clin Rev Allergy Immunol 32(3):199–200

    Article  CAS  PubMed  Google Scholar 

  41. Ramos-Casals M, Brito-Zerón P, Seror R et al (2015) EULAR Sjögren Syndrome Task Force. Characterization of systemic disease in primary Sjögren’s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology 54(12):2230–2238. https://doi.org/10.1093/rheumatology/kev200. (Erratum in: Rheumatology (Oxford). 2017 Jul 1;56(7):1245)

    Article  PubMed  PubMed Central  Google Scholar 

  42. Seror R, Bootsma H, Saraux A et al (2016) EULAR Sjögren’s Task Force. Defining disease activity states and clinically meaningful improvement in primary Sjögren’s syndrome with EULAR primary Sjögren’s syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis 75(2):382–389. https://doi.org/10.1136/annrheumdis-2014-206008

    Article  CAS  PubMed  Google Scholar 

  43. Semb AG, Rollefstad S, van Riel P et al (2014) Cardiovascular disease assessment in rheumatoid arthritis: a guide to translating knowledge of cardiovascular risk into clinical practice. Ann Rheum Dis 73(7):1284–1288. https://doi.org/10.1136/annrheumdis-2013-204792

    Article  PubMed  Google Scholar 

  44. Crowson CS, Rollefstad S, Ikdahl E, A Trans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA) et al (2018) Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis. Ann Rheum Dis 77(1):48–54. https://doi.org/10.1136/annrheumdis-2017-211735

    Article  CAS  PubMed  Google Scholar 

  45. Boumpas DT, Austin HA, Vaughn EM et al (1992) Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340(8822):741–745

    Article  CAS  PubMed  Google Scholar 

  46. Bertsias GK, Ioannidis JP, Aringer M et al (2010) EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 69(12):2074–2082. https://doi.org/10.1136/ard.2010.130476

    Article  CAS  PubMed  Google Scholar 

  47. Bertsias GK, Tektonidou M, Amoura Z et al (2012) European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association. Joint European League against Rheumatism and European Renal Association-European Dialysis and Association T (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 71(11):1771–1782. https://doi.org/10.1136/annrheumdis-2012-201940

    Article  CAS  PubMed  Google Scholar 

  48. Andreoli L, Bertsias GK, Agmon-Levin N et al (2017) EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 76(3):476–485. https://doi.org/10.1136/annrheumdis-2016-209770

    Article  CAS  PubMed  Google Scholar 

  49. Moulton VR, Tsokos GC (2015) T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity. J Clin Invest 125(6):2220–2227. https://doi.org/10.1172/JCI78087

    Article  PubMed  PubMed Central  Google Scholar 

  50. Tsokos GC, Lo MS, Costa Reis P, Sullivan KE (2018) New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol 12(12):716–730. https://doi.org/10.1038/nrrheum.2016.186

    Article  CAS  Google Scholar 

  51. Sfikakis PP, Kaklamanis PH, Elezoglou A et al (2004 Mar) Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease. Ann Intern Med 2(5):404–406 140(

    Article  Google Scholar 

  52. Hatemi G, Christensen R, Bang D et al (2018) 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Ann Rheum Dis 77(6):808–818. https://doi.org/10.1136/annrheumdis-2018-213225

    Article  PubMed  Google Scholar 

  53. International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD) (2014) The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28(3):338–347. https://doi.org/10.1111/jdv.12107

    Article  Google Scholar 

  54. Zhang W, Doherty M, Leeb BF et al (2007) EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR Standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 66(3):377–388

    Article  CAS  PubMed  Google Scholar 

  55. Zhang W, Doherty M, Leeb BF et al (2009) EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann Rheum Dis 68(1):8–17. https://doi.org/10.1136/ard.2007.084772

    Article  CAS  PubMed  Google Scholar 

  56. Sakkas LI, Chikanza IC, Platsoucas CD (2006) Mechanisms of disease: the role of immune cells in the pathogenesis of systemic sclerosis. Nat Clin Pract Rheumatol 2(12):679–685

    Article  CAS  PubMed  Google Scholar 

  57. Mavropoulos A, Simopoulou T, Varna A et al (2016) Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis. Arthritis Rheumatol 68(2):494–504. https://doi.org/10.1002/art.39437

    Article  CAS  PubMed  Google Scholar 

  58. Daoussis D, Liossis SN, Tsamandas AC et al (2010) Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study. Rheumatology 49(2):271–280. https://doi.org/10.1093/rheumatology/kep093

    Article  CAS  PubMed  Google Scholar 

  59. Daoussis D, Tsamandas A, Antonopoulos I et al (2016) B cell depletion therapy upregulates Dkk-1 skin expression in patients with systemic sclerosis: association with enhanced resolution of skin fibrosis. Arthritis Res Ther 18(1):118. https://doi.org/10.1186/s13075-016-1017-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Markatseli TE, Voulgari PV, Alamanos Y, Drosos AA (2011) Prognostic factors of radiological damage in rheumatoid arthritis: a 10-year retrospective study. J Rheumatol 38(1):44–52. https://doi.org/10.3899/jrheum.100514. (Epub 2010 Oct 15)

    Article  PubMed  Google Scholar 

  61. Braun J, Baraliakos X (2018) Active and chronic sacroiliitis, spondylitis and enthesitis, how specific are imaging findings for axial spondyloarthritis? Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/key372. (Epub ahead of print)

    Article  Google Scholar 

  62. Smolen JS, Schöls M, Braun J et al (2018) Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis 77(1):3–17. https://doi.org/10.1136/annrheumdis-2017-211734 (Erratum in: Ann Rheum Dis. 2018 Mar;77(3):472)

    Article  PubMed  Google Scholar 

  63. Koutsianas C, Thomas K, Vassilopoulos D (2017) Hepatitis B reactivation in rheumatic diseases: screening and prevention. Rheum Dis Clin N Am 43(1):133–149. https://doi.org/10.1016/j.rdc.2016.09.012

    Article  Google Scholar 

  64. Thomas K, Vassilopoulos D (2016) Immunization in patients with inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 30(5):946–963. https://doi.org/10.1016/j.berh.2016.10.009

    Article  PubMed  Google Scholar 

  65. Sakkas LI, Bogdanos DP (2018) Multiple hit infection and autoimmunity: the dysbiotic microbiota-ACPA connection in rheumatoid arthritis. Curr Opin Rheumatol 30(4):403–409. https://doi.org/10.1097/BOR.0000000000000503

    Article  CAS  PubMed  Google Scholar 

  66. Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM (2004) Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum 50(8):2569–2579

    Article  PubMed  Google Scholar 

  67. Abreu MM, Danowski A, Wahl DG et al (2015) The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th International Congress on antiphospholipid antibodies technical task force report on antiphospholipid syndrome clinical features. Autoimmun Rev 14(5):401–414. https://doi.org/10.1016/j.autrev.2015.01.002

    Article  PubMed  Google Scholar 

  68. Dimitroulas T, Giannakoulas G, Papadopoulou K et al (2010) Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction. J Rheumatol 37(5):993–999. https://doi.org/10.3899/jrheum.090931

    Article  PubMed  Google Scholar 

  69. Mavrogeni SI, Kitas GD, Dimitroulas T et al (2016) Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use. Int J Cardiol 217:135–148. https://doi.org/10.1016/j.ijcard.2016.04.158

    Article  PubMed  Google Scholar 

  70. Smolen JS, Landewé R, Bijlsma J et al (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960–977. https://doi.org/10.1136/annrheumdis-2016-210715

  71. Radner H, Chatzidionysiou K, Nikiphorou E et al (2018) 2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis. Ann Rheum Dis 77(4):476–479. https://doi.org/10.1136/annrheumdis-2017-212256.

    Article  PubMed  Google Scholar 

  72. Sakkas LI, Davas EM, Kapsalaki E et al (1976) Hematogenous spondylitis in central Greece. Spine (Phila PA) 34:E513–E518

    Article  Google Scholar 

  73. Andrianakos A, Trontzas P, Christoyannis F et al (2003) Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study. J Rheumatol 30(7):1589–1601

    PubMed  Google Scholar 

  74. Andrianakos A, Trontzas P, Christoyannis F et al (2006) Prevalence and management of rheumatoid arthritis in the general population of Greece—the ESORDIG study. Rheumatology 45(12):1549–1554

    Article  CAS  PubMed  Google Scholar 

  75. Anagnostopoulos I, Zinzaras E, Alexiou I et al (2010) The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet Disord 11:98

    Article  PubMed  PubMed Central  Google Scholar 

  76. Trontzas P, Andrianakos A, Miyakis S et al (2005) Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clin Rheumatol 24(6):583–589

    Article  CAS  PubMed  Google Scholar 

  77. Andrianakos AA, Kontelis LK, Karamitsos DG et al (2006) Prevalence of symptomatic knee, hand, and hip osteoarthritis in Greece. The ESORDIG study. J Rheumatol 33(12):2507–2513

    PubMed  Google Scholar 

  78. Andrianakos AA, Miyakis S, Trontzas P et al (2005) The burden of the rheumatic diseases in the general adult population of Greece: the ESORDIG study. Rheumatology 44(7):932–938

    Article  CAS  PubMed  Google Scholar 

  79. Sfikakis PP, Bournia V-K, Sidiropoulos P et al (2017) Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database. Clin Exp Rheumatol 35(4):579–585

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lazaros I. Sakkas.

Ethics declarations

Conflict of interest

Author LIS has received speaker honoraria from Actelion, Janssen, Novartis, Abbvie, Roche Sanofi- Aventis, Pfizer. Author Panagiotis Trontzas has received speaker honoraria from Menarini, UCB, Pfizer, Roche, Bristol-Meyers Squibb, Novartis, Pfizer, MSD.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sakkas, L.I., Tronzas, P. The Greek (Hellenic) rheumatology over the years: from ancient to modern times. Rheumatol Int 39, 947–955 (2019). https://doi.org/10.1007/s00296-019-04261-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-019-04261-4

Keywords

Navigation